Trgovina Jaguar Health, Inc. - JAGX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | - | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | N/A |
Odpri* | N/A |
Enoletna sprememba* | N/A |
Dnevni razpon* | N/A |
Razpon 52 wk | 0.73-61.13 |
Povprečni obseg (10 dni) | 4.31M |
Povprečni obseg (3 meseci) | 24.98M |
Tržna kapitalizacija | 2.19M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 4.03M |
Prihodki | 10.78M |
EPS | -58.95 |
Dividenda (donosnost v %) | N/A |
Beta | 1.94 |
Datum naslednjega zaslužka | May 8, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|
Jaguar Health, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
Prihodki | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
Celotni stroški prihodkov | 2.333 | 3.28 | 3.81581 | 2.76575 | 0.88041 |
Bruto dobiček | 2.002 | 6.105 | 1.95945 | 1.6504 | 3.48078 |
Celotni odhodki iz poslovanja | 45.796 | 37.896 | 39.6643 | 34.5802 | 39.0853 |
Celotna prodaja/splošni/upravni stroški Odhodki | 25.997 | 20.996 | 20.4389 | 22.1088 | 14.3314 |
Raziskave in razvoj | 15.079 | 6.413 | 5.81982 | 5.15475 | 4.26946 |
Nenavadni odhodki (prihodki) | 2.387 | 7.207 | 9.58971 | 4.55093 | 19.604 |
Prihodki iz poslovanja | -41.461 | -28.511 | -33.889 | -30.1641 | -34.7241 |
Prihodki (odhodki) od obresti, neto Neoperativni | -10.374 | -5.488 | -4.72125 | -2.29767 | -0.51429 |
Drugo, neto | -0.765 | 0.19 | 0.08083 | 0.31569 | 0.08855 |
Čisti dobiček pred obdavčitvijo | -52.6 | -33.809 | -38.5294 | -32.1461 | -35.1499 |
Čisti dobiček po davkih | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
Čisti dobiček pred dodatnimi postavkami | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
Čisti dobiček | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
Total Adjustments to Net Income | 0 | -4.839 | -6.18681 | ||
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
Popravljen čisti dobiček | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
Popravljene ponderirane povprečne delnice | 0.59601 | 0.1717 | 0.02206 | 0.00093 | 0.01287 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -88.2458 | -225.09 | -2027.26 | -34495.6 | -1707.42 |
Dividends per Share - Common Stock Primary Issue | |||||
Popravljen normalizirani dobiček na enoto čistega dobička | -84.2408 | -183.115 | -1744.73 | -29612.1 | -717.051 |
Skupaj izredne postavke | 0 | ||||
Manjšinski delež | 0.005 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 3.15 | 2.921 | 2.625 | 2.08 | 0.63 |
Prihodki | 3.15 | 2.921 | 2.625 | 2.08 | 0.63 |
Celotni stroški prihodkov | 0.613 | 0.456 | 0.455 | 0.469 | 0.617 |
Bruto dobiček | 2.537 | 2.465 | 2.17 | 1.611 | 0.013 |
Celotni odhodki iz poslovanja | 13.046 | 9.4 | 16.566 | 12.902 | 10.159 |
Celotna prodaja/splošni/upravni stroški Odhodki | 6.493 | 6.493 | 8.979 | 6.951 | 6.23 |
Raziskave in razvoj | 5.94 | 2.451 | 4.945 | 5.482 | 3.312 |
Nenavadni odhodki (prihodki) | 0 | 0 | 2.187 | 0 | 0 |
Prihodki iz poslovanja | -9.896 | -6.479 | -13.941 | -10.822 | -9.529 |
Prihodki (odhodki) od obresti, neto Neoperativni | -2.555 | -1.827 | -5.054 | -2.747 | -2.643 |
Drugo, neto | -0.158 | -1.084 | 0.831 | -0.749 | -0.02 |
Čisti dobiček pred obdavčitvijo | -12.609 | -9.39 | -18.164 | -14.318 | -12.192 |
Čisti dobiček po davkih | -12.609 | -9.39 | -18.164 | -14.318 | -12.192 |
Čisti dobiček pred dodatnimi postavkami | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
Čisti dobiček | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
Total Adjustments to Net Income | 0 | 0 | |||
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
Popravljen čisti dobiček | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
Popravljene ponderirane povprečne delnice | 1.41781 | 1.06239 | 0.99178 | 0.61775 | 0.61105 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -8.83053 | -8.81695 | -18.1351 | -23.1696 | -19.9525 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -8.83053 | -8.81695 | -15.9299 | -23.1696 | -19.9525 |
Manjšinski delež | 0.089 | 0.023 | 0.178 | 0.005 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 28.434 | 17.792 | 9.52235 | 8.14994 | 3.7991 |
Denarna sredstva in kratkoročne naložbe | 17.051 | 8.09 | 3.49543 | 2.56819 | 0.5207 |
Denarna sredstva in ustrezniki | 0.5207 | ||||
Celotne terjatve, neto | 2.144 | 4.56 | 1.69458 | 1.0018 | 0.46904 |
Accounts Receivable - Trade, Net | 1.709 | 4.532 | 1.69171 | 0.99568 | 0.46766 |
Total Inventory | 4.9 | 2.782 | 2.12869 | 3.34218 | 2.07282 |
Prepaid Expenses | 4.339 | 2.36 | 1.26274 | 1.23777 | 0.49737 |
Other Current Assets, Total | 0 | 0.94091 | 0 | 0.23917 | |
Total Assets | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
Property/Plant/Equipment, Total - Net | 1.734 | 0.677 | 0.71021 | 0.76062 | 1.22207 |
Other Long Term Assets, Total | 0.446 | 0.037 | 0.15397 | 0.42083 | 0 |
Total Current Liabilities | 15.471 | 13.22 | 15.3924 | 26.6588 | 15.3858 |
Accounts Payable | 4.929 | 4.759 | 5.35154 | 5.41426 | 7.35493 |
Accrued Expenses | 7.357 | 4.493 | 3.2589 | 4.93944 | 2.19955 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 4.84558 | 1.14115 |
Current Port. of LT Debt/Capital Leases | 3.184 | 3.789 | 6.77846 | 11.2392 | 4.28146 |
Other Current Liabilities, Total | 0.001 | 0.179 | 0.00349 | 0.22038 | 0.40867 |
Total Liabilities | 41.654 | 25.641 | 15.8424 | 26.6588 | 26.3682 |
Total Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
Other Liabilities, Total | 0.919 | 0 | |||
Total Equity | 11.611 | 17.202 | 20.568 | 14.3831 | 17.261 |
Redeemable Preferred Stock | 0 | 0 | 11.6065 | 9 | 0 |
Common Stock | 0.005 | 0.011 | 0.00546 | 0.00649 | 0.01053 |
Additional Paid-In Capital | 231.1 | 184.09 | 142.046 | 99.9274 | 79.6552 |
Retained Earnings (Accumulated Deficit) | -219.494 | -166.899 | -133.09 | -94.5508 | -62.4047 |
Total Liabilities & Shareholders’ Equity | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
Total Common Shares Outstanding | 50.4733 | 40.1279 | 45.0589 | 40.4184 | 42.6378 |
Goodwill, Net | 0 | 5.21082 | |||
Intangibles, Net | 22.651 | 24.337 | 26.0239 | 31.7106 | 33.3972 |
Cash | 17.051 | 8.09 | 3.49543 | 2.56819 | |
Property/Plant/Equipment, Total - Gross | 2.032 | 0.942 | 0.93428 | ||
Accumulated Depreciation, Total | -0.298 | -0.265 | -0.22407 | ||
Total Preferred Shares Outstanding | 0 | 0 | 5.53706 | ||
Minority Interest | 0.242 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 28.474 | 28.434 | 24.005 | 44.294 | 44.104 |
Denarna sredstva in kratkoročne naložbe | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
Cash | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
Celotne terjatve, neto | 2.255 | 2.144 | 2.205 | 4.174 | 5.927 |
Accounts Receivable - Trade, Net | 1.795 | 1.709 | 2.111 | 4.134 | 5.897 |
Total Inventory | 4.879 | 4.9 | 4.513 | 3.402 | 2.821 |
Prepaid Expenses | 3.884 | 4.339 | 4.912 | 4.806 | 3.106 |
Other Current Assets, Total | 9.92 | 0 | |||
Total Assets | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
Property/Plant/Equipment, Total - Net | 1.757 | 1.734 | 1.7 | 1.751 | 0.674 |
Property/Plant/Equipment, Total - Gross | 2.18 | 2.032 | 1.99 | 2.033 | 0.948 |
Accumulated Depreciation, Total | -0.423 | -0.298 | -0.29 | -0.282 | -0.274 |
Intangibles, Net | 22.229 | 22.651 | 23.072 | 23.494 | 23.916 |
Other Long Term Assets, Total | 0.446 | 0.446 | 10.478 | 0 | 0.019 |
Total Current Liabilities | 19.093 | 15.471 | 11.951 | 12.652 | 12.592 |
Accounts Payable | 3.708 | 4.929 | 3.786 | 4.918 | 4.74 |
Accrued Expenses | 8.494 | 7.357 | 6.381 | 6.582 | 6.409 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 6.89 | 3.184 | 1.781 | 1.145 | 1.431 |
Other Current Liabilities, Total | 0.001 | 0.001 | 0.003 | 0.007 | 0.012 |
Total Liabilities | 44.861 | 41.654 | 37.703 | 37.754 | 36.822 |
Total Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
Total Equity | 8.045 | 11.611 | 21.552 | 31.785 | 31.891 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.008 | 0.005 | 0.005 | 0.014 | 0.013 |
Additional Paid-In Capital | 245.517 | 231.1 | 226.728 | 224.76 | 210.786 |
Retained Earnings (Accumulated Deficit) | -237.48 | -219.494 | -205.181 | -192.989 | -178.908 |
Total Liabilities & Shareholders’ Equity | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
Total Common Shares Outstanding | 79.1948 | 50.4733 | 48.2117 | 47.8944 | 44.7563 |
Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.921 | 0.919 | 0.826 | 0.907 | |
Minority Interest | 0.064 | 0.242 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
Denarna sredstva iz poslovanja | -34.97 | -15.278 | -20.4568 | -22.7308 | -9.82494 |
Denarna sredstva iz poslovanja | 1.719 | 1.727 | 1.73708 | 1.319 | 0.58434 |
Nedenarne postavke | 13.644 | 20.271 | 17.0073 | 9.02132 | 20.6123 |
Denarna sredstva Plačane obresti | 0.028 | 0.757 | 0.142 | 0.01934 | 0.23455 |
Spremembe v obratnem kapitalu | 2.267 | -3.467 | -0.66177 | -0.9251 | 4.12831 |
Denarna sredstva pri naložbenju | -0.006 | -0.007 | 0 | -0.00653 | -1.55734 |
Kapitalski izdatki | -0.006 | -0.007 | -0.00653 | 0 | |
Celotne druge postavke denarnih tokov pri naložbenju | 0 | 0 | -1.55734 | ||
Denarna sredstva pri financiranju | 43.937 | 19.492 | 21.772 | 24.5457 | 10.6799 |
Postavke denarnega toka pri financiranju | -0.731 | -1.008 | -2.57481 | -2.11755 | 0 |
Izdaja (odplačilo) delnic, neto | 35.615 | 7.756 | 24.4468 | 25.8797 | 10.302 |
Izdaja (odplačilo) dolga, neto | 9.053 | 12.744 | -0.1 | 0.78349 | 0.37791 |
Neto sprememba denarnih sredstev | 8.961 | 4.207 | 1.31519 | 1.80832 | -0.70241 |
Deferred Taxes | 0 | -13.1812 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -18.164 | -52.6 | -38.282 | -26.09 | -12.009 |
Cash From Operating Activities | -7.695 | -34.97 | -26.047 | -16.615 | -6.708 |
Cash From Operating Activities | 0.426 | 1.719 | 1.29 | 0.861 | 0.431 |
Non-Cash Items | 7.583 | 13.644 | 10.601 | 7.609 | 4.695 |
Cash Interest Paid | 0.011 | 0.028 | 0.021 | 0.008 | 0.006 |
Changes in Working Capital | 2.46 | 2.267 | 0.344 | 1.005 | 0.175 |
Cash From Investing Activities | -0.006 | -10.484 | -0.006 | 0 | |
Capital Expenditures | -0.006 | -0.006 | -0.006 | 0 | |
Cash From Financing Activities | 8.15 | 43.937 | 40.816 | 40.443 | 30.868 |
Financing Cash Flow Items | -0.335 | -0.731 | -0.623 | -0.268 | -0.095 |
Issuance (Retirement) of Stock, Net | 9.11 | 35.615 | 32.386 | 31.608 | 21.86 |
Issuance (Retirement) of Debt, Net | -0.625 | 9.053 | 9.053 | 9.103 | 9.103 |
Net Change in Cash | 0.405 | 8.961 | 4.285 | 23.822 | 24.16 |
Other Investing Cash Flow Items, Total | -10.478 | ||||
Foreign Exchange Effects | -0.05 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Jaguar Health, Inc. Company profile
O družbi Jaguar Health, Inc.
Jaguar Health, Inc. je farmacevtsko podjetje v komercialni fazi. Podjetje se osredotoča na razvoj rastlinskih, neopioidnih in trajnostno pridobljenih zdravil na recept za ljudi in živali z gastrointestinalnimi (GI) težavami, vključno s kronično in izčrpavajočo diarejo. Družba posluje v dveh segmentih: zdravje ljudi in zdravje živali. Segment zdravja živali se osredotoča na razvoj in trženje zdravil na recept in brez recepta za spremljevalne in proizvodne živali. Podjetje Canalevia-CA1 se uporablja pri diareji pri psih, ki jo povzroča kemoterapija. Segment zdravja ljudi je osredotočen na razvoj in trženje izdelkov za ljudi in tekoče trženje zdravila Mytesi, ki se uporablja za simptomatsko lajšanje neinfekcijske driske pri odraslih z virusom humane imunske pomanjkljivosti (HIV)/sindromom pridobljene imunske pomanjkljivosti (AIDS) na protiretrovirusni terapiji. Njegova hčerinska družba v popolni lasti je Napo Pharmaceuticals, Inc.
Industry: | Bio Therapeutic Drugs |
200 Pine Street Suite 400
SAN FRANCISCO
CALIFORNIA 94104
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com